Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / BIOTECH ETF
-
Total 13F shares
-
1,095,196
-
Share change
-
+140,690
-
Total reported value
-
$170,725,902
-
Put/Call ratio
-
54%
-
Price per share
-
$156.05
-
Number of holders
-
109
-
Value change
-
+$21,683,598
-
Number of buys
-
28
-
Number of sells
-
44
Institutional Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q2 2023
As of 30 Jun 2023,
VANECK ETF TRUST - BIOTECH ETF (BBH) was held by
109 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,095,196 shares.
The largest 10 holders included
Miller Investment Management, LP, GOLDMAN SACHS GROUP INC, MORGAN STANLEY, JPMORGAN CHASE & CO, Qube Research & Technologies Ltd, BANK OF AMERICA CORP /DE/, LPL Financial LLC, MOGY JOEL R INVESTMENT COUNSEL INC, Royal Bank of Canada, and Consolidated Investment Group LLC.
This page lists
111
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.